INTRODUCTION
The numbers of perinatal HIV infections continue to decline in nearly all highly resourced countries, including the United States. [1] [2] [3] Despite these declines, in the past decade, a number of highly resourced countries have reported among their HIV-exposed and HIV-infected populations increasing percentages of children born in less-resourced countries, notably sub-Saharan Africa (SSA). [4] [5] [6] [7] [8] [9] During 2007-2011, of the children aged ,13 years in the United States with diagnosed HIV infection, 33% were born outside the United States 10 and of these, 62% were born in Africa. As of January 2010, the HIV immigration exclusion was lifted in the United States, 11 and HIV was no longer included in the list of screening tests recommended for immigration. 12 To better understand the contribution of birthplace to the epidemiology of diagnosed HIV infection among children, we analyzed data from the National HIV Surveillance System (NHSS) of the Centers for Disease Control and Prevention (CDC).
METHODS
We analyzed data from NHSS reported to CDC through June 2016 for children aged ,13 years with diagnosed HIV infection in the United States during 2008-2014, by place of birth and selected characteristics. Data were reported from 50 states and the District of Columbia. A minimum of 18-month delay was allowed for the reporting of deaths to NHSS.
As part of NHSS, surveillance jurisdictions collect data on persons with diagnosed HIV infection in accordance with state and territorial laws and report the data to CDC without personal identifying information. New cases of HIV infection among children are identified through active follow-up of HIV-infected pregnant women and HIV-exposed infants in conjunction with case reporting through providers and laboratory reporting of HIV-related test results. An HIV diagnosis is based on the earliest laboratory or physician-documented report associated with confirmed HIV infection after the US HIV surveillance case definition. 13 Case information is collected on standardized case report forms, which are completed by providers or through active follow-up by health department staff (ie, abstracting data from medical records at reporting facilities). 14 This report only includes those children with a residence in the United States and the District of Columbia at the time of HIV diagnosis. This includes children who may have had an earlier diagnosis in another country, but who lacked laboratory or physician-documented evidence of the earlier diagnosis in the other country. Birthplace information was available for 92.5% of persons included in this analysis. We defined US born as children who were born in the 50 states, the District of Columbia, or a US dependent area (American Samoa, Guam, the Northern Mariana Islands, Puerto Rico, the Republic of Palau, and the US Virgin Islands). For this analysis, the only US dependent area that had children with HIV infection diagnosed in the 50 states and the District of Columbia was Puerto Rico. We defined foreign born as children with a known place of birth outside of the 50 states, the District of Columbia, and the US dependent areas. The date of immigration to the United States and current age at immigration are not collected through NHSS.
Determination of age was based on the child's age at the date of the first documented HIV diagnosis in the United States. For foreign-born children included in the analysis who may have had an earlier diagnosis in another country but who lacked laboratory or physician-documented evidence of the earlier diagnosis, their age represents age at first documented diagnosis in the United States. Data on child's race were classified according to the minimum categories specified by the 1997 Office of Management and Budget Revisions to the Standards for the Classification of Federal Data on Race and Ethnicity. 15 Children of Hispanic/Latino ethnicity can be of any race. 15 Transmission category was classified as perinatal or other/unknown (other includes hemophilia, blood transfusion, and other confirmed risk factor; unknown includes risk factor not reported or not identified). Of the children included in this analysis who had diagnosed HIV infections attributed to other/unknown, 97.4% had no identified risk.
All comparisons are between US-born and foreign-born children, unless stated otherwise. Because of the high percentage of missing data for many of the characteristics, particularly among foreign-born infants and their mothers, for comparison, percentages were calculated based on cases with available information. In a few instances, the results include data not shown in Table 2 (eg, data on children with diagnosed HIV infection whose transmission category was classified as other/unknown).
RESULTS
During 2008-2014, there were 1516 children aged ,13 years with diagnosed HIV infection (hereafter referred to as "children") in 50 states and the District of Columbia (Table  1) , of whom 726 (47.9%) were US born, 676 (44.6%) were foreign born, and 114 (7.5%) had unknown or missing place of birth. A 26.7% decrease was seen in the annual number of children with diagnosed HIV infection in 50 states and the District of Columbia from 240 in 2008 to 176 in 2014.
The number of US-born children with diagnosed HIV infection decreased 57.1% from 2008 to 2014; the number of US-born children with perinatally acquired HIV infection followed a similar pattern, with a 60.1% decline. US-born children accounted for 70.0% of all children with diagnosed HIV infection in 2008, declining to a low of 32.3% in 2013 ( Table 1 ). The overall number of foreign-born children increased annually (except during 2011) through 2012 (n = 147) and then declined in 2013 and 2014; the number of foreign-born children with perinatally acquired HIV infection followed a similar pattern. The numbers of US-born and foreign-born children were nearly equal in 2011 (89 and 94, respectively). Since 2011, among all children, the numbers of foreign born have always exceeded those of US born. Overall, the percentage with missing place of birth information remained fairly small throughout the study period (5.4% in 2008 and 10.8% in 2014). Among all children, those with a transmission category of other/unknown (1) always had a higher proportion of foreign born than US born, (2) never constituted less than 22.4% of foreign-born children, and (3) increased in their percent of foreign-born children through 2011, declining slightly thereafter. Table 2 shows clinical characteristics of children with diagnosed perinatally acquired HIV infection and known place of birth. All comparisons are between US-born and foreign-born children, unless stated otherwise. Because of the high percentage of missing data for many of the characteristics, particularly among foreign-born infants and their mothers, for comparison, percentages were calculated based on cases with available information. In a few instances, the results include data not shown in Table 2 (eg, data on children with diagnosed HIV infection whose transmission category was classified as other/unknown).
The age at which the children received their HIV diagnosis was younger for US-born children (0-18 months, 72.6%; 5-12 years, 16.9%), compared with foreign-born children (0-18 months, 9.8%; 5-12 years, 60.3%). Among US-born and foreign-born children, children whose transmission category was classified as other/unknown received their diagnosis at older ages (5-12 years: US born, 47.4%; foreign born, 51.8%; data not shown in Table 2 ).
Black/African American race predominated in both US born (62.9%) and foreign born (68.8%); white race was reported slightly less often among US born (9.4%) than foreign born (13.7%). By contrast, Hispanic/Latino was the second-most frequent racial/ethnic identification among USborn children (18.0%), but among foreign-born children, Asian race (7.4%) was more frequent than Hispanic/Latino (6.5%) ethnicity. Similarly, among foreign-born children whose transmission category was classified as other/ unknown, Asian race was 7.0%, and Hispanic/Latino ethnicity was 1.9% (data not shown in Table 2 ).
Among mothers of US-born children with known timing of maternal HIV diagnosis, diagnosis was before the pregnancy in 49.7%, during pregnancy in 16.6%, and after birth in 23.7%. By contrast, among mothers of foreign-born children with data available (n = 173), maternal HIV diagnosis was made before pregnancy in 21.4%, during pregnancy in 13.9%, and after delivery in 41.0%. Among US-born children, 48.2% did not have information on mother's prenatal care (PNC). Among those with information on mother's PNC, 77.7% of mothers had at least 1 PNC visit; among those whose mothers had any PNC, 62.4% of mothers began care before the third trimester. Data on PNC were available for ,2% of mothers of foreign-born children. Among US-born children with antiretroviral (ARV) medication use information, 51.8% of their mothers had received ARVs prenatally and 19.8% of their mothers had received ARVs during labor and delivery; 100% of infants had received ARVs neonatally. The use of ARVs prenatally, natally, and postnatally only occurred in 9.5% of motherinfant pairs with known ARV use information. By contrast, for foreign-born children and their mothers, data on ARV use were available in 7%-12% (the available data usually showed that no prenatal or natal ARV was used). Data on breastfeeding were missing from many mothers of US-born (34.2%) and foreign-born (90.7%) children, but among those with data, breastfeeding was reported by mothers of 13.6% of US-born and 65.1% of foreign-born children. Data for mother's place of birth were missing for 22.2% of US-born and 61.8% of foreign-born children. Among mothers of US-born children with available data (n = 498), 80% were born in the United States or a US dependent area and 20% were born elsewhere, whereas ,1% of mothers of foreign-born children were born in the United States.
Medicaid or other public funds were the payer source for 82.4% of US-born children. Although data on medical payer status were missing for 75.3% of foreign-born, among those with data (n = 112), 64% reported private coverage and 29.8% had Medicaid or other publically funded payer source.
At the time of diagnosis, US-born children resided predominantly in the South (57.1%), in contrast to foreignborn children, among whom residence was more widely and evenly distributed: south (30.8%), midwest (27.8%), west (29.5%), and northeast (11.9%). For those with information on facility of diagnosis (461 US born; 394 foreign born), a greater percentage of the US-born children had HIV infections diagnosed in inpatient facilities (51.2%) than outpatient facilities (44.9%), in contrast to the foreign-born children, among whom HIV infections were diagnosed less frequently in inpatient facilities (19.0%) than outpatient facilities (72.3%). Children whose transmission category was classified as other/unknown showed a similar pattern: US-born children had slightly more HIV infections diagnosed in inpatient facilities (36.6%) than outpatient (33.1%), and foreign-born children had infections diagnosed less often in inpatient facilities (19.8%) than outpatient facilities (57.8%) (data not shown).
Among children with information on child's primary caretaker, biological parents were more often the custodian among US-born (71.9%) than among foreign-born (34.2%) children, although the percentage where the custodian was another relative (or a related foster or adoptive parent) was similar (US born, 11.9%; foreign born, 10.4%). By contrast, custody was with a foster or nonrelated adoptive parent for 10.4% of US-born but for a majority (55.1%) of foreignborn children.
The region of birth for the 676 children born outside the United States but with HIV diagnosed within the United States from 2008 to 2014 is shown in Table 3 (data are not shown for individual countries). Of these children, 443 (65.5%) were born in SSA (note that Sudan is considered SSA). Approximately half of the 676 were born in East Africa, of whom 69.1% were born in Ethiopia, followed by 14.4% from Uganda. There were 51 children from West Africa (7.5%), with Nigeria and Ghana accounting for 35.3% and 33.3%, respectively; there were 33 from Middle Africa (4.9%), of whom 51.5% were from Congo and 24.2% were from Cameroon. Eastern Europe accounted for 14.3% of non US-born children (68.0% of whom were from Ukraine and 28.9% from the Russian Federation); these 2 former republics of the Soviet Union, along with Latvia, accounted for 98.9% of Eastern European children, and with Uzbekistan (counted as South Central Asia), accounted for 15.2% of the foreignborn children. 
DISCUSSION
During the period 2008-2014 in the United States, the overall number of children aged ,13 years with diagnosed HIV infection declined significantly, with an even larger percentage decline in the number of US-born children with diagnosed HIV. Concurrently, there was an increase-at least up until the last couple of years of the observation period-in the annual number and percentage of foreign-born children with diagnosed HIV infection. The increase in foreign-born children appears to have begun before January 2010, when the HIV immigration exclusion was lifted. 11 Notably, of the foreign-born children diagnosed with HIV in the United States in this study, 55% were in nonfamilial foster or adoptive custody. We are not able to determine how many of these children entered the country under a waiver of the HIV immigration restriction which was rescinded in 2010. The US regions in which foreign-born children reside reflect the regions of the United States which receive the largest numbers of immigrants in general. 16 In our study, half of the foreign-born children with diagnosed HIV infection were born in East Africa, mainly Ethiopia, but it is notable that 3 of the top 5 countries of birth for foreign-born children were not in Africa.
The increasing contribution of foreign-born children to the HIV epidemic in the United States is significant for several reasons. Focusing on perinatal transmissions that occur in the United States allows a more accurate perspective on the effectiveness of domestic prevention programs. Beyond those considerations, however, are those which relate specifically to the issues of HIV-infected infants and children who immigrate to the United States with their families. It has yet to be examined whether these children are linked to and maintained in care at rates different from US-born children. Experience in Canada has suggested that a multicultural approach and more case management might be necessary. 8 Another significant consideration is the diagnosis of HIV infections among children who immigrate with their parents who might have undiagnosed HIV infection. Diagnostic nucleic acid tests widely available in North America (eg, Roche Amplicor 1.5 HIV DNA PCR), where HIV subtype B predominates, appear to detect with comparable sensitivity and specificity other subtypes that circulate in SSA, specifically, subtype C, [17] [18] [19] [20] subtypes A and D, 20 and subtype CRF01_AE in Southeast Asia. 21 Despite the utility of the nucleic acid tests presently in use, pediatricians in the United States will need to consider that the optimal time for such testing will differ for children who have breastfed as infants in Africa or who continue to breastfeed once they have arrived in the United States. In this study, about two-thirds of foreign-born children with diagnosed HIV had breastfed, among those for whom information on breastfeeding was known. Even if HIV-exposed infants who immigrate here were tested in Africa, up to 70% of such infants drop out of care early. 22 As would be expected, children with perinatally acquired HIV infection in Africa are older at the time of diagnosis than are infected children born in the United States. 23 Given the high loss to follow-up of HIV-exposed infants in SSA, 24 we should consider the possibility that HIVexposed infants born elsewhere who move here at very young ages might not yet have undergone sufficient diagnostic testing to rule out HIV infection. In this study, HIV in foreign-born children was diagnosed at older ages than in USborn. In addition to the attributes of foreign-born children just noted (higher rate of breastfeeding and older age at time of diagnosis), other differences between US-born and foreignborn children were evident. Fewer mothers of foreign-born children had HIV diagnosed before pregnancy and more after delivery. Medical coverage was more often by private insurance, probably reflecting the higher percent of foreign born who were adopted. The clinical setting differed in which 6 In 27 countries of the European Union (plus Norway and Iceland), of 57 persons whose HIV infection was attributed to mother-to-child transmission during 1996-2006, 23% had been born in SSA. 7 Through 2006, in United Kingdom and Ireland, of 1441 HIV infected reported to the National Study of HIV in Pregnancy and Childhood and the Collaborative HIV Paediatric Study, 664 (46%) had been born elsewhere, of whom 564/1441 (39%) had been born in Africa. 9 Higher resource countries are also reporting high, and in some cases, increasing percentages of foreign birth among HIV-infected women delivering infants. The number of HIV-infected women giving birth who were themselves born in another country has increased: in France, from 12% in the early-mid 1980s to 45.4% in the mid-late 1990s to 64% in 2003-2004 27 ; in Italy, from 12% to 26% during the period from the mid-1980s to 2005 28 ; and in United Kingdom/Ireland from 43.5% in the early 1990s to 78.6% in 2004-2005. 1 Immigration and international travel have a significant role in the epidemiology of several other infectious diseases in the United States. The most notable example is tuberculosis, for which cases in immigrants have constituted a majority since 2001, 29 reaching 66% in 2014. 30 Hepatitis B has been more prevalent among immigrants than US-born persons for many years; during 1999-2006, overall prevalence among foreign-born was 12.2% (95% confidence interval: 10.7% to 13.9%) and among US-born persons was 3.5% (95% confidence interval: 3.1% to 3.8%). 31 As cases of rubella declined in the years just before its elimination in the Western Hemisphere, foreign-born persons accounted for 79% of cases in 1998 and 65% of cases in 1999, with 50% during 2001-2004. 32 Similarly, among measles cases occurring since 2001, 88% were internationally imported. 33 There are several limitations to our study. The NHSS does not include data on the date of entry into the United States, so we were not able to relate any of our variables to citizenship status or an individual's time in the country. The greater proportion of missing data among the foreign born vs. US born makes it difficult to assess certain characteristics for the foreign born. In addition, we were not able to analyze linkage to care among US-born and foreign-born children with diagnosed HIV infection. The marker for linkage to care is a record of at least 1 CD4 T-lymphocyte (CD4) or viral load test performed #1 or #3 months after diagnosis and was available only in a subset of jurisdictions during the study period, making the data insufficient as a basis for comparison. Finally, this report only includes those children with a US residence at the time of HIV diagnosis, as those residing in the United States but born and HIV-diagnosed abroad are excluded.
The numbers and percentages of foreign-born children with diagnosed HIV infection in the United States have exceeded those of US-born children for several years. It is unknown how long this discrepancy will continue, but it is clear from our data that further attention will need to be paid to issues such as linkage to and retention in HIV care among HIV-infected children born abroad. In addition, as more HIVinfected women immigrate to the United States, new issues may arise related to prevention of perinatal transmission, such as innate resistance of HIV-2, diminished sensitivity of nucleic acid tests commonly used for diagnosis, and awareness of transmission risks related to breastfeeding.
